Cocrystal Share Price

Cocrystal Share Price

NASDAQ: COCP | Micro Cap | Healthcare
$0.93
-$0.11 (-10.58%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Cocrystal Stock Performance

Open
N/A
Prev. Close
$1.04
Circuit Range
N/A
Day Range
N/A
Year Range
$0.87 - $1.99
Volume
N/A
Average Traded
N/A

Cocrystal Share Price Chart

Line chart of the Cocrystal price trend over the selected period. The price fell overall, ranging from 0.93 to 0.93, ending at 0.93.
$0.00$0.00
L
Show Current Price
H

Cocrystal Stock Fundamentals & Key Indicators

Market Cap
$10.50M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.59
Revenue (TTM)
$0.00
Return On Equity (TTM)
-423.66%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-41.56%

Cocrystal Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.23$0.11$0.11
Net Profit-$2.43-$2.30-$3.16-$3.44
Net Profit MarginN/A-1000.00%-2872.73%-3127.27%
Income ChangeN/A5.35%-37.39%-8.86%

Cocrystal Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$38.84-$17.98-$17.50-$8.83
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A53.71%2.67%49.54%

Cocrystal Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1.581.882.170.66
Current Assets8.1311.5829.0940.18
Total Assets9.7113.4631.2640.84
Non Current Liabilities1.171.511.610.06
Current Liabilities2.212.433.261.22
Total Liabilities3.383.934.881.27
Shareholders' Equity6.339.5226.3839.57

Cocrystal Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-8.19-16.49-14.67-21.44
Investing-0.01-0.01-0.12-0.07
Financing5.370.03.99-0.03

Corporate Actions

Split
Ex-date: 11 Oct 2022

About Cocrystal

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

Cocrystal Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.09
$0.93
-4.62%
Oct 2026
$1.14
$0.97
-13.33%
Sep 2026
$1.14
$1.13
-2.17%
Aug 2026
$0.96
$1.15
+32.64%
Jul 2026
$1.06
$0.87
-17.03%
Jun 2026
$1.14
$1.04
-5.00%
May 2026
$1.41
$1.10
-23.08%
Apr 2026
$1.03
$1.43
+43.00%
Mar 2026
$1.02
$1.00
-4.76%
Feb 2026
$0.98
$1.05
+6.06%
Jan 2026
$0.99
$0.99
+2.06%
Dec 2025
$1.04
$0.97
+4.19%

Cocrystal Share Price FAQs